UK MHRA approves trofolastat for diagnostic imaging of prostate cancer in men: United Kingdom Monday, March 31, 2025, 15:00 Hrs [IST] The Medicines and Healthcare products Regulat ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory ...

Seven new CERSIs came together to showcase how partnerships will modernise regulation in AI, clinical trials, and advanced therapies, bringing ...

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...

The Clarkson's Farm star shared some of the negative side effects he experienced while taking Ozempic for weight loss.

Covering medical devices and medicines, the bulletins are part of the MHRA’s three-year strategy to improve safety ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...

As with all products, the MHRA will keep its safety under close review. Prostate cancer is one of the most common cancers in ...

A landmark study looking at all adverse drug reactions ever recorded in Britain since 1964 reveals just three genes could be ...

A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect ...

England’s patient safety commissioner has warned that patients with vision or hearing impairments are at greater risk from medicines and medical devices because their views are not sufficiently ...

A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the ...